Results 11 to 20 of about 36,179 (151)

Daunorubicin metabolism: estimation of daunorubicin reductase [PDF]

open access: yesBritish Journal of Pharmacology, 1971
Summary Daunorubicin reductase, an enzyme ubiquitous in all mammalian tissues tested, converts daunorubicin, a cancer chemotherapeutic antibiotic, to daunorubicinol. A method for the estimation of daunorubicinol and daunorubicin reductase is described.
N R, Bachur, D H, Huffman
openaire   +2 more sources

Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial

open access: yesPharmaceutics, 2022
Daunorubicin pharmacokinetics (PK) are characterised by an important inter-individual variability, which raises questions about the optimal dose regimen in patients with acute myeloid leukaemia.
Guillaume Drevin   +12 more
doaj   +1 more source

Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment

open access: yesBMC Cancer, 2021
Background Daunorubicin is used clinically in the treatment of myeloma, acute lymphatic and myelocytic leukaemia. The toxic lesions caused by daunorubicin induce various modes of cell death, including apoptosis.
Hussain Mubarak Al-Aamri   +3 more
doaj   +1 more source

Effects of Royal Jelly on Apoptosis and the Expression of Apoptotic Genes on Testicular Tissue in Male Balb/C Mice Treated with Daunorubicin [PDF]

open access: yesJournal of Mazandaran University of Medical Sciences, 2023
Background and purpose: Daunorubicin is an effective drug in chemotherapy, but its clinical use is limited due to serious side effects. Royal jelly as a natural compound obtained from bees can be helpful in preventing the damage caused by daunorubicin ...
Mansour Safaei Pourzamani   +4 more
doaj  

Evaluation of nanoscaled dual targeting drug-loaded liposomes on inhibiting vasculogenic mimicry channels of brain glioma

open access: yesArtificial Cells, Nanomedicine, and Biotechnology, 2021
Brain glioma is the most common primary tumour of the central nervous system. Complete surgical removal of the brain glioma is virtually impossible. Chemotherapy is still an important treatment for brain glioma.
Hong-Jun Xie   +6 more
doaj   +1 more source

Checkpoint Kinase 1 Activation Enhances Intestinal Epithelial Barrier Function via Regulation of Claudin-5 Expression. [PDF]

open access: yesPLoS ONE, 2016
Several stressors are known to influence epithelial tight junction (TJ) integrity, but the association between DNA damage and TJ integrity remains unclear.
Akihiro Watari   +3 more
doaj   +1 more source

Casein-Based Nanoparticles: A Potential Tool for the Delivery of Daunorubicin in Acute Lymphocytic Leukemia

open access: yesPharmaceutics, 2023
The aim of this study was to develop casein-based nanoscale carriers as a potential delivery system for daunorubicin, as a pH-responsive targeting tool for acute lymphocytic leukemia.
Nikolay Zahariev   +3 more
doaj   +1 more source

Inhibitory Action of Daunorubicin on Lipopolysaccharide-Stimulated Inducible-Type Nitric Oxide Synthase Induction in Alveolar Macrophages

open access: yesJournal of Pharmacological Sciences, 2005
The purpose of this study was to investigate the effects of daunorubicin on lipopolysaccharide (LPS)-stimulated inducible-type nitric oxide synthase (iNOS) expression in macrophages.
Fumiaki Saito   +3 more
doaj   +1 more source

Oxaliplatin combined with daunorubicin induces apoptosis of colon cancer cell line HT-29 [PDF]

open access: yesJichu yixue yu linchuang, 2020
Objective To study the mechanism of oxaliplatin combined with daunorubicin on the apoptosis of colon cancer cells. Methods Colon cancer cells HT-29 were incubated with different concentrations of oxaliplatin and daunorubicin respectively, MTT assay was ...
TIAN Chun-yang, LIU Xiao-zheng, FAN Jun-chao
doaj  

Alternating electric fields can improve chemotherapy treatment efficacy in blood cancer cell U937 (non-adherent cells)

open access: yesBMC Cancer, 2023
Background Recent achievements in cancer therapy are the use of alternating electrical fields at intermediate frequencies (100–300 kHz) and low intensities (1–3 V/cm), which specifically target cell proliferation while affecting different cellular ...
Elham Homami   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy